T. S. Lin

430 total citations
9 papers, 345 citations indexed

About

T. S. Lin is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, T. S. Lin has authored 9 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in T. S. Lin's work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Advanced Breast Cancer Therapies (2 papers). T. S. Lin is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Advanced Breast Cancer Therapies (2 papers). T. S. Lin collaborates with scholars based in United States and Canada. T. S. Lin's co-authors include Charles G. Drake, Allan J. Fox, John C. Byrd, James T. Dalton, Rajeswaran Mani, Fengting Yan, Rosa Lapalombella, Robert A. Baiocchi, Xiaoli Zhang and Ching-Shih Chen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

T. S. Lin

9 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. S. Lin United States	7	250	135	61	48	38	9	345
Daisuke Muta Japan	10	221 0.9×	61 0.5×	33 0.5×	42 0.9×	52 1.4×	18	321
Ryotaro Suzuki Japan	10	122 0.5×	61 0.5×	51 0.8×	60 1.3×	63 1.7×	38	303
Swantje Mindorf Germany	6	152 0.6×	60 0.4×	48 0.8×	18 0.4×	29 0.8×	7	323
Jussi Leppävirta Finland	6	346 1.4×	103 0.8×	39 0.6×	126 2.6×	111 2.9×	9	406
Mary Jane Petruzzi United States	6	146 0.6×	72 0.5×	158 2.6×	30 0.6×	10 0.3×	7	328
S. Rumpler Austria	7	104 0.4×	92 0.7×	103 1.7×	16 0.3×	22 0.6×	11	252
Isis Atallah Switzerland	6	111 0.4×	78 0.6×	49 0.8×	29 0.6×	15 0.4×	15	182
Gill Spurlock United Kingdom	8	232 0.9×	107 0.8×	33 0.5×	88 1.8×	50 1.3×	10	257
Vladimír Balik Czechia	8	108 0.4×	42 0.3×	127 2.1×	20 0.4×	53 1.4×	36	312
Kim Uhas United States	4	106 0.4×	53 0.4×	110 1.8×	32 0.7×	59 1.6×	4	259

Countries citing papers authored by T. S. Lin

Since Specialization

Citations

This map shows the geographic impact of T. S. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. S. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. S. Lin more than expected).

Fields of papers citing papers by T. S. Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. S. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. S. Lin. The network helps show where T. S. Lin may publish in the future.

Co-authorship network of co-authors of T. S. Lin

This figure shows the co-authorship network connecting the top 25 collaborators of T. S. Lin. A scholar is included among the top collaborators of T. S. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. S. Lin. T. S. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Liu, Qing, Lapo Alinari, Ching-Shih Chen, et al.. (2010). FTY720 Shows Promising In vitro and In vivo Preclinical Activity by Downmodulating Cyclin D1 and Phospho-Akt in Mantle Cell Lymphoma. Clinical Cancer Research. 16(12). 3182–3192. 47 indexed citations

Flinn, Ian W., John C. Byrd, Richard R. Furman, et al.. (2009). Preliminary evidence of clinical activity in a phase I study of CAL-101, a selective inhibitor of the p1108 isoform of phosphatidylinositol 3-kinase (P13K), in patients with select hematologic malignancies. Journal of Clinical Oncology. 27(15_suppl). 3543–3543. 15 indexed citations

Alinari, Lapo, Qing Liu, Ching‐Shih Chen, et al.. (2009). FTY720 Demonstrates Promising in-Vitro and in-Vivo Pre-Clinical Activity by Down-Modulation of Cyclin D1 and Pakt in Mantle Cell Lymphoma.. Blood. 114(22). 3728–3728. 1 indexed citations

Byrd, John C., Ian W. Flinn, TJ Kipps, et al.. (2008). Lumiliximab in combination with FCR for the treatment of relapsed chronic lymphocytic leukemia (CLL): results from a phase I/II multicenter study. Journal of Clinical Oncology. 26(15_suppl). 7003–7003. 6 indexed citations

Lin, T. S., Leslie A. Andritsos, Jeffrey A. Jones, et al.. (2008). Activity of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed, genetically high risk chronic lymphocytic leukemia (CLL). Journal of Clinical Oncology. 26(15_suppl). 7007–7007. 7 indexed citations

Byrd, John C., T. S. Lin, James T. Dalton, et al.. (2006). Pharmacologically derived schedule of flavopiridol has significant efficacy in refractory, genetically high risk chronic lymphocytic leukemia (CLL). Journal of Clinical Oncology. 24(18_suppl). 6516–6516. 7 indexed citations

Lin, T. S., Beth Fischer, Mollie E. Moran, et al.. (2006). Flavopiridol, fludarabine and rituximab (FFR) is an active regimen in indolent B-cell lymphoproliferative disorders and mantle cell lymphoma (MCL). Journal of Clinical Oncology. 24(18_suppl). 7599–7599. 3 indexed citations

Lin, T. S., Jeffrey S. Johnston, James T. Dalton, et al.. (2005). Combination Bortezomib (PS341, Velcade) and Rituximab Treatment Affects Multiple Survival and Death Pathways To Promote Apoptosis in Mantle Cell Lymphoma.. Blood. 106(11). 2407–2407. 6 indexed citations

Lin, T. S., Allan J. Fox, & Charles G. Drake. (1989). Regrowth of aneurysm sacs from residual neck following aneurysm clipping. Journal of neurosurgery. 70(4). 556–560. 253 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact